Market Forecast by Countries (United States, Canada), By Product (Consumables, Instruments), By Application (Stem Cell Technology, Cancer Research, Drug Screening and Development, Tissue Engineering & Regenerative Medicine, Others), By End-user (Research Institutes, Pharmaceutical & Biotechnology Companies, Others) And Competitive Landscape
Product Code: ETC182201 | Publication Date: May 2021 | Updated Date: Jan 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 250 | No. of Figures: 50 | No. of Tables: 25 | |
Report Name | North America Cell culture Market |
Forecast Period | 2025-2031 |
Forecast Size | USD 13.33 billion By 2031 |
CAGR | 0.058 |
Growing Sector | Healthcare |
North America Market Cell culture report thoroughly covers the market By Countries, By Product, By Application, and By End-user. The market outlook report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
North America Cell culture Market was valued at USD 5.99 billion and is expected to reach USD 13.33 billion , growing at a CAGR of around 5.8% from 2025-2031.The growth is driven by increasing investments in biopharmaceutical research, rising demand for regenerative medicine, and the expansion of vaccine production in the region. Additionally, growing interest in personalized medicine and advancements in cell-based therapies are expected to further fuel the market's expansion over the forecast period.
North America Cell culture Market has shown notable growth, driven by increasing investments in biotechnology, pharmaceuticals, and academic research sectors. This market is essential for the development of innovative healthcare solutions, including vaccines, therapeutic proteins, and regenerative medicine. Key factors such as the rise in chronic disease prevalence, the expanding biopharmaceutical sector, and technological advancements in cell culture methods are propelling the market forward.
According to 6Wresearch, North America Cell Culture Market size is estimated to grow steadily, reaching at a CAGR of 5.8% during the forecast period of 2025-2031. The growth of the industry is experiencing notable growth, propelled by the rising demand for biopharmaceuticals, the expansion of the biotechnology industry, and increased research in the fields of oncology, immunology, and regenerative medicine.
Furthermore, the North America is witnessing a surge in investments from both public and private sectors in research and development activities, which is expected to bolster North America Cell Culture Market Growth. However, the market faces certain restraints, such as the high cost of cell biology research and a lack of infrastructure in some American countries, which could impede progress. Despite these challenges, emerging opportunities abound, particularly in the adoption of 3D cell culture technologies and the increasing focus on personalized medicine, which are set to revolutionize the North America Cell Culture Industry in the coming years.
The North America Cell Culture Market is witnessing the adoption of advanced technologies and methods, including 3D cell culture techniques, to improve drug discovery and reduce testing time. These innovations are expected to drive market growth in the coming years. Furthermore, there is a growing interest in personalized medicine, which involves tailoring medical treatments to individual patients based on their genetic makeup and other factors. This approach requires extensive use of cell culture techniques for drug discovery and development, making it a key driver for market expansion.
North America offers lucrative investment opportunities in the cell culture industry, particularly in the United States and Canada. The region is home to some of the top pharmaceutical companies and research institutions, making it a hub for biotechnology and cell biology research. This presents ample opportunities for investors looking to enter the market or expand their existing operations.
Moreover, with increased government funding towards healthcare infrastructure and R&D activities, there is a growing focus on advanced therapeutic options such as regenerative medicine and gene therapy. These areas require extensive use of cell culture techniques, providing further avenues for investment in the North America market.
Some of the key players operating in the North America Cell culture Market include Thermo Fisher Scientific, GE Healthcare, Merck KGaA, BD Biosciences, Lonza Group AG, Corning Incorporated, Sartorius AG, and Irvine Scientific. These companies are continuously expanding their product portfolios and investing in research activities to stay ahead in the highly competitive market.
Government regulations play a crucial role in the performance of the North America Cell culture Market. In the US, cell culture products and related research activities are regulated by the Food and Drug Administration (FDA) under the Code of Federal Regulations Title 21. This ensures safety, efficacy, and quality standards for biological products used in cell culture.
In Canada, Health Canada regulates cell culture products under the Canadian Biologics and Radiopharmaceuticals Division (BRD), which also enforces strict guidelines to ensure product safety and effectiveness. These regulatory bodies play a critical role in maintaining market stability and promoting consumer trust in cell culture products.
The report offers a comprehensive study of the subsequent market segments and their leading categories.
According to Dhaval, Research Manager, 6Wresearch, the US is expected to dominate the North America Cell Culture Market, owing to its well-established biotechnology and pharmaceutical industries. Additionally, the presence of major players in this country is contributing significantly to market growth.
The consumables segment is expected to dominate the North America Cell Culture Market, driven by the continuous use of culture media, sera, and reagents in cell culture experiments. With advancements in technology and increasing demand for 3D cell culture techniques, there is a growing need for specialized consumables, further propelling market growth.
The drug screening and development segment is expected to dominate the North America Cell Culture Market, due to the continuous demand for new and improved drugs for various diseases. This includes cancer research, where cell culture techniques are extensively used to study and develop new treatments.
The pharmaceutical and biotechnology companies are expected to dominate the North America Cell Culture Market by end-user, owing to their extensive use of cell culture techniques in drug discovery and development. These companies have a high demand for specialized cell culture products and services, making them the key contributors to market growth.
The report offers a comprehensive study of the subsequent market segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Cell culture Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Cell culture Market Revenues & Volume, 2021 & 2031F |
3.3 North America Cell culture Market - Industry Life Cycle |
3.4 North America Cell culture Market - Porter's Five Forces |
3.5 North America Cell culture Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Cell culture Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.7 North America Cell culture Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.8 North America Cell culture Market Revenues & Volume Share, By End-user, 2021 & 2031F |
3.9 North America Cell culture Market Revenues & Volume Share, By , 2021 & 2031F |
4 North America Cell culture Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Cell culture Market Trends |
6 North America Cell culture Market, 2021 - 2031 |
6.1 North America Cell culture Market, Revenues & Volume, By Product, 2021 - 2031 |
6.2 North America Cell culture Market, Revenues & Volume, By Application, 2021 - 2031 |
6.3 North America Cell culture Market, Revenues & Volume, By End-user, 2021 - 2031 |
7 United States Cell culture Market, 2021 - 2031 |
7.1 United States Cell culture Market, Revenues & Volume, By Product, 2021 - 2031 |
7.2 United States Cell culture Market, Revenues & Volume, By Application, 2021 - 2031 |
7.3 United States Cell culture Market, Revenues & Volume, By End-user, 2021 - 2031 |
8 Canada Cell culture Market, 2021 - 2031 |
8.1 Canada Cell culture Market, Revenues & Volume, By Product, 2021 - 2031 |
8.2 Canada Cell culture Market, Revenues & Volume, By Application, 2021 - 2031 |
8.3 Canada Cell culture Market, Revenues & Volume, By End-user, 2021 - 2031 |
9 North America Cell culture Market Key Performance Indicators |
10 North America Cell culture Market - Opportunity Assessment |
10.1 North America Cell culture Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Cell culture Market Opportunity Assessment, By Product, 2021 & 2031F |
10.3 North America Cell culture Market Opportunity Assessment, By Application, 2021 & 2031F |
10.4 North America Cell culture Market Opportunity Assessment, By End-user, 2021 & 2031F |
10.5 North America Cell culture Market Opportunity Assessment, By , 2021 & 2031F |
11 North America Cell culture Market - Competitive Landscape |
11.1 North America Cell culture Market Revenue Share, By Companies, 2024 |
11.2 North America Cell culture Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Company Profiles |
13 Recommendations |
14 Disclaimer |